Progress towards a dengue vaccine.

The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue. A safe and effective vaccine for dengue is urgently needed. The pathogenesis of se...

Full description

Bibliographic Details
Main Authors: Webster, D, Farrar, J, Rowland-Jones, S
Format: Journal article
Language:English
Published: 2009
_version_ 1826280487238238208
author Webster, D
Farrar, J
Rowland-Jones, S
author_facet Webster, D
Farrar, J
Rowland-Jones, S
author_sort Webster, D
collection OXFORD
description The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue. A safe and effective vaccine for dengue is urgently needed. The pathogenesis of severe dengue results from a complex interaction between the virus, the host, and, at least in part, immune-mediated mechanisms. Vaccine development has been slowed by fears that immunisation might predispose individuals to the severe form of dengue infection. A pipeline of candidate vaccines now exists, including live attenuated, inactivated, chimeric, DNA, and viral-vector vaccines, some of which are at the stage of clinical testing. In this Review, we present what is understood about dengue pathogenesis and its implications for vaccine design, the progress that is being made in the development of a vaccine, and the future challenges.
first_indexed 2024-03-07T00:14:26Z
format Journal article
id oxford-uuid:7a5729c8-42c8-4873-8a52-4c4a355abc98
institution University of Oxford
language English
last_indexed 2024-03-07T00:14:26Z
publishDate 2009
record_format dspace
spelling oxford-uuid:7a5729c8-42c8-4873-8a52-4c4a355abc982022-03-26T20:43:21ZProgress towards a dengue vaccine.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a5729c8-42c8-4873-8a52-4c4a355abc98EnglishSymplectic Elements at Oxford2009Webster, DFarrar, JRowland-Jones, SThe spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue. A safe and effective vaccine for dengue is urgently needed. The pathogenesis of severe dengue results from a complex interaction between the virus, the host, and, at least in part, immune-mediated mechanisms. Vaccine development has been slowed by fears that immunisation might predispose individuals to the severe form of dengue infection. A pipeline of candidate vaccines now exists, including live attenuated, inactivated, chimeric, DNA, and viral-vector vaccines, some of which are at the stage of clinical testing. In this Review, we present what is understood about dengue pathogenesis and its implications for vaccine design, the progress that is being made in the development of a vaccine, and the future challenges.
spellingShingle Webster, D
Farrar, J
Rowland-Jones, S
Progress towards a dengue vaccine.
title Progress towards a dengue vaccine.
title_full Progress towards a dengue vaccine.
title_fullStr Progress towards a dengue vaccine.
title_full_unstemmed Progress towards a dengue vaccine.
title_short Progress towards a dengue vaccine.
title_sort progress towards a dengue vaccine
work_keys_str_mv AT websterd progresstowardsadenguevaccine
AT farrarj progresstowardsadenguevaccine
AT rowlandjoness progresstowardsadenguevaccine